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Abstract
Aim Each year almost 15,000 Danish women are diagnosed
with cervical dysplasia, a precursor to cervical cancer. The
period of medical follow-up, or ‘watchful waiting’,t o
monitor for regression or progression of the lesion before
deciding if treatment by conisation is necessary can be
long. The aim of this study was to examine the experiences
of women with different stages of cervical dysplasia and to
examine whether their knowledge of human papillomavirus
(HPV) as the cause of cervical dysplasia influenced their
perception of their disease.
Subject and methods We used focus group and individual
interviews with 12 women diagnosed with different stages
of cervical dysplasia—women who had and had not been
conised. Interview guides were prepared on the basis of a
literature review that identified important issues and
questions for the participants.
Results The participants considered cervical dysplasia to be
a highly distressing condition and experienced monitoring
as a worrying delay before regression of the lesions or
treatment could be initiated. Women expressed a fear of
cancer that was not proportional to the stage of their
dysplasia, but was determined by their degree of knowledge
about their condition. Unlike other sexually transmitted
diseases, information about HPV did not result in stigma-
tisation as the perception of this disease was dominated by
cancer.
Conclusion This study showed that it is extremely impor-
tant to address women’s fears, their need for information
and to ensure better communication with medical practi-
tioners about cervical dysplasia immediately after diagno-
sis, irrespective of the disease stage.
Keywords Cervical dysplasia.Human papillomavirus.
Disease perception
Introduction
Cervical dysplasia, the abnormal growth of cells of the
uterine cervix (also known as cervical intraepithelial
neoplasia or CIN), is a precancerous lesion. It is estimated
that 90% of these lesions regress spontaneously while the
others progress into a more severe lesion and possibly
cancer. Persistent infection with human papillomavirus
(HPV) is a necessary cause of cervical dysplasia (Bosch
and Lorincz 2002; Trottier and Franco 2006; Smith et al.
2007). Cervical dysplasia can be detected at an early stage
by the Papanicolaou (Pap) cytological smear test. It can
then be monitored regularly for regression of the lesion, or
progression, before deciding if treatment by conisation is
necessary (Bjerregaard 2007; National Board of Health
2007a). The introduction of cervical screening programmes
b a s e do nt h eP a ps m e a rh a sr e s u l t e di ns i g n i f i c a n t
reductions in the incidence of cervical cancer, although
some 37,000 women in Europe still die from this disease
each year (Engholm et al. 2008).
Cervical cancer is the second most common cancer in
women worldwide. In Europe the incidence was estimated
The results of this study have been published previously in Ugeskrift
for læger, a Danish medical journal (Mortensen and Adeler 2009).
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DOI 10.1007/s10389-010-0330-1to be 33,441 in 2002 (Ferlay et al. 2004). In Denmark,
which has a population of about 5 million, the lifetime risk
of developing cervical cancer is 1%, and every year
approximately 400 new cases of cervical cancer are
diagnosed and about 175 women die from the disease
(Clemmensen et al. 2006; National Board of Health 2007b).
Since the introduction of organised cervical screening for
women aged 23–60 years in Denmark in the 1960s, there
has been a 50% decrease in the prevalence of cervical
cancer, but the incidence of cervical cancer remains one of
the highest in the European Union (Engholm et al. 2008;
Clemmensen et al. 2006).
Each year, approximately 14,800 Danish women
receive a Pap smear result that indicates a cervical lesion
or abnormality of varying degrees of severity (Fig. 1)
(Clemmensen et al. 2006). The follow-up and clinical
management of these women depends on the specific
cytological changes identified, which are classified accord-
ing to the Bethesda system (National Board of Health
2007a) and explained to the patient as “mild”, “moderate”
or “severe” cell changes (Fig. 1). In the case of mild
changes, including atypical squamous cells of undeter-
mined significance (ASCUS), atypical glandular cells
(AGC) or low-grade squamous intraepithelial lesions
(LSIL), the patient is monitored by Pap test every 6 months
to 1 year to determine whether the dysplasia regresses or
progresses. Women with moderate changes, such as
atypical squamous cells, cannot exclude high-grade squa-
mous intraepithelial lesion (HSIL) (ASC-H), HSIL or
severe changes, including adenocarcinoma in situ (AIS),
are referred to a private or hospital-based gynaecologist
who examines the cervix by colposcopy and performs a
biopsy. Some women with moderate changes (HSIL) may
be managed by ‘watchful waiting’, which involves moni-
toring by colposcopy every 3 months, and they will be
treated only if the lesion is seen to progress. Cases of severe
dysplasia and cancer in situ are managed by conisation
(conical section or cone biopsy), which is the surgical
removal (under sedation or general anaesthetic) of a cone-
shaped sample of cervical tissue. This is used as a
diagnostic tool as well as treatment, if the histological
analysis of the sample shows that all the abnormal tissue
has been successfully removed. In Denmark, approximately
1 in 3 women (5,000) with an abnormal Pap result undergo
conisation each year (National Board of Health 2007a;
Danish Gynaecological Cancer 2007; Bro et al. 2008).
Currently, HPV testing in the setting of cervical cancer
screening is not routinely performed in Denmark.
The period of watchful waiting between diagnosis of a
lesion and confirmation of regression or need for treatment
may last for several years and can be associated with a
considerable psychological burden, as suggested by a
number of studies in the literature (Lauver et al. 1999;
French et al. 2004, 2006; Lerman et al. 1991; Ideström et
al. 2003;N e a l ee ta l .2003; Campion et al. 1988;
McCaffery et al. 2004; Fleurence et al. 2007; Hounsgaard
2004; Waller et al. 2005; McCaffery et al. 2006). Overall,
the results of these mainly quantitative studies show that
women diagnosed with cervical dysplasia worried about the
development of cancer. They often fear death and suffer
from anxiety, stress and depression associated with worries
about their sex life, fertility, medical supervision and
potential interventions. The results show that women’s lack
of knowledge and poor doctor-patient communication can
contribute to their anxiety (Lauver et al. 1999; French et al.
2004, 2006; Lerman et al. 1991; Ideström et al. 2003; Neale
et al. 2003; Campion et al. 1988; McCaffery et al. 2004;
Fleurence et al. 2007; Hounsgaard 2004). Women’s
knowledge about HPV is generally poor (Waller et al.
2005; McCaffery et al. 2006), but providing women with
information about HPVand its role in cervical dysplasia has
been shown to have both positive and negative effects. On
the one hand, a better understanding has been reported to
have a negative influence on women’s perception of their
condition, causing them to perceive it as a stigmatising
sexually transmitted disease and producing feelings of
shame, guilt and low self-esteem (Goffman 1968). Infor-
mation about the high prevalence of HPV has, on the other
hand, been reported to improve health-related behaviour
(e.g. attendance at organised screening, use of condoms)
(Waller et al. 2005, 2007; McCaffery et al. 2006; Kahn et
al. 2005, 2007; Maissi et al. 2004; Clarke et al. 1996;
McCree and Dempsey 2005).
The aim of this qualitative study, the first of its kind in a
Danish context, was to examine the experiences of young
women aged 25–35 years diagnosed with cervical dyspla-
sia. In particular we looked at the ways in which they had
been affected by the diagnosis and subsequent follow-up
and treatment. We focused on the women’s own under-
standing of the stage of their disease and its course,
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Fig. 1 Distribution of abnormal Pap smear results in Danish
pathology departments in 2006 according to the Bethesda classifica-
tion 2006 (National Board of Health 2007b). ASC atypical squamous
cells, AGC atypical glandular cells, LSIL low-grade squamous intra-
epithelial lesions, HSIL high-grade squamous intraepithelial lesion,
AIS adenocarcinoma in situ
474 J Public Health (2010) 18:473–482distinguishing between women who had undergone conisa-
tion and those who had not. We also sought to determine
whether knowledge about HPVaffected the women’s percep-
tions of their disease. Patients’ perceptions of a disease are
known to be related to their socio-cultural context and these
perceptionscaninfluence the wayinwhichtheycopewiththe
disease (Bishop 1991;K l e i n m a n1988;H a h n1984).
Methods
Qualitative research methods can provide insights into the
qualities of a phenomenon and the meanings that patients
ascribe to it. The results can be generalised analytically,
though not statistically (Malterud 2004), and can give a
detailed understanding of the patients’ perceptions of their
illness. We used focus group and individual interviews to
obtain as broad a range of perspectives on cervical
dysplasia as possible. Focus groups were chosen to create
a confidential environment in which women could openly
discuss their experiences with cervical dysplasia, allowing
us to gain insights into the social construction of meaning
and the perception of this disease among women who had
or had not undergone conisation, while individual inter-
views provided additional in-depth narratives about per-
sonal experiences with cervical dysplasia (Berger and
Luckmann 1987; Halkier 2003; Bech Risør et al. 2005;
Kvale 1996; Spradley 1979).
Recruitment of study participants
The participants were recruited from the practices of three
private general practitioners (GPs) and two gynaecologists
in the cities of Aarhus and Aalborg, Denmark, and from the
gynaecology and obstetrics outpatient ward at Skejby
Hospital, Aarhus, Denmark. Women aged between 25 and
35 years, who did not have any serious co-morbidity and
who had either been diagnosed with cervical dysplasia
within the past 3 months or had had a conical section within
the past 6 months were eligible for inclusion. This age
range was selected because of the high prevalence of
cervical dysplasia. We did not seek the official diagnosis for
the specific stage of cervical dysplasia for the women from
their medical records since what was important was the
women’s own understanding of their stage (mild, moderate
or severe dysplasia) and whether they had or had not been
conised. We selected more women who had undergone
conisation because they would have a longer experience of
living with their condition and would be able to talk about
how they felt before and after the conisation. Women were
invited to participate in either an individual interview or in
a focus group. We had individual interviews with one
woman who had not undergone conisation and one who
had (Table 1). Focus groups were organised with people of
similar age to improve comparability of results and to
facilitate honest and open group discussions. Also, since the
topic was considered to be personal and potentially
sensitive, we decided it was important that the focus groups
included only a few participants. If the groups are too big
Table 1 Brief description of women included in focus groups or
individual interviews
Woman’s
number
Brief description
Individual interview
1 Woman who had not undergone conisation:
abnormal smear test result 3 years before the
interview, declared free of cervical dysplasia
2 weeks before the interview
5 Woman who had undergone conisation: monitored
for 8 months before conisation and 3-month
follow-up results after conisation not received
Focus group 1: women who had not undergone conisation
2 Abnormal smear test result 8 weeks before the
interview, referred for colposcopy
3 Abnormal smear test result 14 weeks before the
interview, waiting for cytology result
4 Abnormal smear test result 4 weeks before the
interview, referred directly for conisation
Focus group 2: women who had undergone conisation
6 Referred directly for colposcopy and conisation
after initial abnormal smear test result; 3-month
follow-up results after conisation showed no
dysplasia; 6-month follow-up results not received
7 Referred directly for colposcopy and conisation
after initial abnormal smear test result; 3-month
follow-up results after conisation showed no
dysplasia; 6-month follow-up results not received
8 Monitored for 24 months before conisation;
3-month follow-up results after conisation
showed no dysplasia; 6-month follow-up
results not received
Focus group 3: women who had undergone conisation
9 Monitored for 18 months before conisation;
3-month follow-up results after conisation
showed no dysplasia; 6-month follow-up
results not received
10 Monitored for 12 months before conisation;
3-month follow-up results after conisation
showed no dysplasia; 6-month follow-up
results not received
11 Monitored for 60 months before conisation;
3-month follow-up results after conisation
showed no dysplasia; 6-month follow-up
results not received
12 Monitored for 3 months before conisation;
3-month follow-up results after conisation
showed no dysplasia; 6-month follow-up
results not received
J Public Health (2010) 18:473–482 475one or two participants could dominate the discussion or
the participants can feel less comfortable talking about
sensitive issues (Halkier 2003).
Women who fulfilled the inclusion criteria were in-
formed orally about the study by the consulting physician
who also gave them a study information sheet. We gave the
physicians an instruction sheet describing how to present
the study to their patients, underlining that the purpose of
the study was to gain in-depth knowledge about the
women’s disease experiences and that no preparation or
prior knowledge about cervical dysplasia were required in
order to participate. Patients wishing to participate then
contacted GLM, who was an independent researcher.
Anonymity and confidentiality were ensured throughout
the study. All women gave their informed consent to
participate and the study did not require Ethics Committee
approval.
Focus group and individual interviews
Semi- and funnel-structured interview guides were used to
moderate the focus groups and structure the individual
interviews. The topics and questions in the interview guides
were selected on the basis of a literature review carried out
before the start of the study. The questions were open-
ended to capture as much information as possible, including
any that had not been envisaged by pre-interview hypo-
theses (Halkier 2003; Kvale 1996). Individual interview
guides were designed to produce an in-depth personal
narrative of disease experience, while the focus group
guides were designed to facilitate discussion. The guide
used for focus group interviews with women who had
undergone conisation is given in Table 2 as an example.
The first focus group was held after working hours in a
staff meeting room at Skejby Hospital. Although this
location was chosen as a neutral but familiar environment,
the participants appeared to be uncomfortable in this setting
and subsequent focus groups and interviews were held in
small meeting rooms in hotels in Aalborg and Aarhus.
The focus group interviews were moderated by GLM
with assistance from a colleague. The individual interviews
were conducted by GLM only. The purpose and design of
the study was explained at the beginning of each interview.
It was emphasised that there were no wrong or right
answers to the questions posed and that the aim was to
obtain a realistic picture of all the participants’ experiences
and thoughts on having cervical dysplasia.
The interviews were transcribed verbatim and analysed
using a discourse theoretical approach to the relationship
between language and the social construction of meaning
(Winther Jørgensen and Phillips 1999). The women’s
statements were seen as an expression as well as an
ongoing construction of the meaning and personal impact
of having cervical dysplasia. This approach is used to
analyse a diversity of statements such that clusters of
meaning are generated and involves an analysis of the
terminology used to speak about the subject and the ways
in which it is related to other issues. Firstly, the data were
coded into the topics that were raised during the dis-
cussions. Secondly, the most important themes within each
topic were identified. Finally, the frequency of and
connections between topics and themes were analysed.
This generated a pattern of the relative meaning that the
different topics and themes had for the participants, i.e. the
women’s most significant experiences associated with
having cervical dysplasia. All methodological and analyt-
ical steps were discussed and alternative interpretations
sought with the authors and with an additional anthropol-
ogist. Disagreements were solved using Spradley’s analyt-
ical process of resolution of qualitative data (Spradley
1979).
Results
In qualitative research, the validity of the results relies more
on data collection until no significant new knowledge can
be generated from it than the number of participants
(Malterud 2004; Kvale 1996; Spradley 1979). In the present
study, this point appeared to be reached after interviews had
been conducted with a total of 12 women.
The characteristics of the women who participated are
summarised in Table 1. Of the four participants who had
not undergone conisation, three women had received their
first abnormal smear test result in the 3 months before the
interview. At the time of the study, one of these women had
been referred for conisation and two were still waiting for
the cytology results. One other woman had recently been
declared free from cervical dysplasia after 3 years of
monitoring. Eight participants had undergone conisation in
the 6 months before the interview. Most of these women
had received the results of the 3-month post-conisation
check-up, but none had yet received the results of the 6-
month check-up. Three of these women had been referred
directly for colposcopy and conisation after receiving the
initial abnormal smear test result. The remaining five
women had been monitored for 1–5 years before being
referred for conisation.
Two focus groups were held with women who had
undergone conisation, one group with three participants and
one with four participants. An individual interview was
conducted with the remaining woman who had undergone
conisation. One focus group was held with three women
who had not undergone conisation; one individual inter-
view was held with a woman who had not undergone
conisation.
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some of the participants’ most important experiences
associated with being diagnosed with cervical dysplasia.
Initial reaction to diagnosis of cervical dysplasia
Most of the participants had reacted with shock, panic or
tears when they received the first abnormal smear test
result; they said it was like receiving a diagnosis of cancer.
Although most of the women knew that this was not the
case, fear and shock made it difficult for them to understand
the explanations provided by the doctor. Many women were
quite unprepared for an abnormal result because they had
considered the test simply as a routine check-up.
He [the doctor] sat there with my medical record and
said: “Well, I see that you have moderate or severe
cervical dysplasia”. What?! My jaw dropped, my eyes
and ears stopped working. I could hardly listen
because of the pounding in my head: “Does this
mean I will have cervical cancer soon? Can I have
children? Can I do this? Can I do that? Am I really
that sick? Although I see nothing on the outside, it’s
all wrong on the inside. I can’t believe I hadn’t
noticed anything.” It was really disturbing. It means
you can actually walk around and develop cancer
without knowing it, right? (Woman who had under-
gone conisation describing her reaction to receiving
the results of her first colposcopy).
Even when the initial panic faded, concerns about the
evolution of the cervical dysplasia typically persisted.
The women continued to fear for their lives and their
fertility and worried about how much treatment they
Table 2 Example of interview guide used for focus groups: women who had undergone a cone biopsy
Interview
stage
Aim Questions
Opening Presentation of participants First name, age, how long suffering from cervical
dysplasia and when they had undergone cone biopsy
Introductory
questions
The participants’ perception
of cervical dysplasia
1. Before going on to your personal experiences with
cervical dysplasia, please describe your views on this disease
Cues: precursor or disease in itself, prevalence, consequences,
cause, treatment options, time to cure
If woman knows about human papillomavirus:
2. When did you get the information?
3. Did it influence your views on cervical dysplasia?
4. Overall, do you feel you have been well informed about cervical dysplasia?
Transitional
questions
The participants’ experiences
with the period up to conisation
5. How did you react when you heard that you had cervical dysplasia?
6. Can you describe the period prior to conisation?
7. How did you react to being told that you needed conisation?
Key questions The effect of cervical dysplasia on
their quality of life after conisation
8. What are your main thoughts on the disease today?
Cues: change in perception of cervical dysplasia, termination of or stage in
the course of disease, future medical supervision, worries about the future
9. Do you feel any physical symptoms or effects from having had cervical dysplasia?
10. Does the dysplasia still affect you psychologically? If yes, how?
Cues: frame of mind (fear, shame, guilt, anger, depression), perception of self
and body, thoughts on the meaning of life, regrets (previous non-attendance
at cervical smear testing), worries about the future, disease phobia?
11. Has cervical dysplasia affected your social life? If yes, how?
Cues: level of support, taboos, concerns about stigma
12. Has the dysplasia affected your love life? If yes, how?
Cues: worries about infidelity, being contagious, conflicts with
and support from partner, disrupted sex life, fear of rejection
13. Has there been a change in the way in which cervical dysplasia
affects you today compared with when you were diagnosed?
Closing
questions
14. In conclusion, how do you assess the communication you had
with medical practitioners throughout the course of the disease?
15. Is there anything you think we ought to have discussed but did not?
The other interview guides were similar and are available from GLM
J Public Health (2010) 18:473–482 477would have to have and for how long they would need
medical supervision.
Discrepancy between severity of dysplasia and level
of anxiety experienced
Our findings suggest that the severity of cervical dysplasia
diagnosed did not correspond to the level of anxiety
experienced; in fact some women with low-grade lesions
(mild dysplasia) who had not been conised appeared to be
more anxious than women who had had higher-grade
lesions (moderate or severe dysplasia) and had been
conised. The difference in anxiety level between these
w o m e ns e e m e dt oc o r r e s p o n dt ot h el e v e lo ft h e i r
knowledge about cervical dysplasia and how long they
had been under medical supervision.
When diagnosed with a low-grade lesion (mild dyspla-
sia), the women said that they had not received much
information about their condition. At this stage, the women
said the follow-up period was extremely wearing and full of
uncertainty; the longer the period of monitoring, the worse
they felt. The unknown duration of follow-up and the
possibility that the dysplasia would become more severe
were worrying. Most of the women currently in this stage
felt that their lives were ‘on stand-by’ and they described
themselves as being sad, irritable and anxious. The
concerns were particularly acute before new tests and when
they were waiting for test results, since these events were
important milestones. Many feared that their condition was
constantly progressing and this considerably increased their
need for explanations and action. At the stage of mild
dysplasia, most of the women did not understand the
meaningof the test results orthe justification for theintervals
between check-ups. Some thought that the intervals between
check-ups were due to the problem of waiting lists in the
health care system. Three women had asked for conisation
simply to put an end to the waiting because they thought
the longer they waited the higher the risk of the condition
‘spreading’.
Several times, I experienced a kind of spontaneous
fear of death. All of a sudden, it was like getting a
bucket of cold water in the face. I’d cry and be sure
that it would never turn out well. At the same time, I
felt ashamed or guilty of making such a fuss about it
because I wasn’t really sick. I found that really, really
difficult […]. It was a great relief [when I was
referred for conisation] because at that point, I’d
been going to the hospital for nearly 1 1/2 years. At
that stage, my life was being measured by: ‘When am
I going to the hospital again?’ Those 2 1/2 to
3 months in-between check-ups… A few days before,
I’d be really, really upset and be thinking that it was
just terrible. Then I’d go, and afterwards I walked
around feeling pain and bleeding for a few days and
then I had to wait 2 weeks to get the test result. I’db e
nervous about what I’d be told. […] then it was only
1 1/2 2 months until I had to go back again. All the
time, I felt that I was counting down to when it was
time to go back. When more than a year had passed, I
became so upset when I was at the hospital that the
doctor said that when I called the next time to get the
result, I could ask the chief consultant about
undergoing conisation before the development of
severe dysplasia. And so I did, and he just laughed
at me and said that it was the most stupid thing he
had ever heard. That I shouldn’t make a big deal of it,
because it wasn’t like I was sick … Obviously, I
became extremely upset and I thought: “Well, it's
probably just me that’s being stupid”. Then 3 months
passed, I went back and it had progressed into severe
dysplasia. At that point, I was like, if it can develop
one stage in 3 months, I’ll be damned if I want to wait
very long for the operation! I was lucky to get a date
for the surgery within 2 weeks. But I was like ‘phew’
[sighing] because they thought I was being ridiculous
because I wanted the operation before it got to that
stage, because I just couldn’t take it anymore. It was too
hard … It really had a negative impact on my quality of
life. (Woman who had undergone conisation).
Reassuring effect of treatment and more information
Five of the women who had undergone conisation had been
through a long period of follow-up before the decision to
operate was taken, and they were therefore able to provide
insights into their experiences with earlier/milder stages of
dysplasia. Where mild cervical dysplasia progressed to a
higher-grade lesion, the necessity for conisation was
upsetting but, at the same time, many women felt relief
that something was finally being done. The three women
who had been referred for colposcopy and conisation
shortly after the initial smear test result had also been
upset, but they were glad that they underwent the operation
promptly (typically within 2 weeks) and that the time of
uncertainty was short. The women who needed conisation
were given more information about cervical dysplasia and
the proposed treatment. This had a reassuring effect and
most of these women thought of conisation as curative and
the subsequent medical follow-up as a precautionary
measure.
At the time of the interviews, most of the participants
who had undergone conisation had received a negative test
result after the 3-month post-conisation check-up. Many
considered the next check-up at 6 months would be a
milestone after which they hoped to be able to move on
478 J Public Health (2010) 18:473–482with their lives. For most, the diagnosis of their disease
made them think about what was important in their lives.
Some felt unsafe after having had a diagnosis of a
potentially fatal disease that was not physically visible.
Effect of information on the mode of transmission of HPV
and its role as the cause of cervical dysplasia
Women who did not know about HPV feared that they were
now predisposed to developing cancer. For many women,
the information provided before conisation included the
role of HPV as the cause of cervical dysplasia. Learning
about the sexual mode of transmission of HPV resulted in
cervical cancer being seen as an unusual form of cancer. It
brought about reflections about infection and re-infection,
but it did not have adverse psychological effects or cause
these women to see cervical dysplasia as stigmatising,
unlike some other sexually transmitted diseases (McCaffery
et al. 2004; Waller et al. 2005; McCaffery et al. 2006;
Goffman 1968; Kahn et al. 2005, 2007; Maissi et al. 2004;
Waller et al. 2007; Clarke et al. 1996;M c C r e ea n d
Dempsey 2005; Lee Mortensen and Larsen 2008). This
was demonstrated by the fact that most of the participants
had spoken openly about the disease not only with their
closest friends and relatives, but also with colleagues and
fellow students. These women viewed sex as a natural part
of life and their perception of their disease was dominated
by the issue of cancer, not that it was a sexually transmitted
disease.
The role of communication with medical practitioners
The results from this study indicated that the women’s
concerns were dependent on the quality of communication
with medical practitioners and the amount of information
provided. The less the women knew about their condition,
the more insecure and worried they felt.
My really sweet gynaecologist said to me: “It’s not like
you’re dying, you know?” No, but it really takes up a
lot of space in my life. I’m not sure that it would have
made such a big difference if I had cancer. All the time,
I felt there was so much uncertainty, uncertainty,
uncertainty. I was headed toward something, but what
was it? (Woman who had undergone conisation
describing the period of waiting before the operation).
Many of the women felt there was a discrepancy
between their own reaction of shock and fear and their
GP’s relatively carefree attitude when they learnt (some-
times over the telephone or from a secretary) about the first
abnormal smear test result. The women felt the need for
clear explanations about the difference between different
stages of dysplasia and actual cancer. Vague expressions
such as a ‘precursor to cancer’ or a ‘precancerous lesion’,
for instance, was not perceived as being essentially
different from cancer itself and tended to increase the
women’s anxiety.
The nurse put her hand on my stomach and said: “…
it looks exactly as it should”. All the muscles of my
body relaxed and then she said: “…but I don’t think
we’re all the way up there yet”. Then the doctor
inserts it a bit more and I could easily see [following
the images on the monitor] that this tissue didn’t look
like the tissue we had just seen. And then the doctor
went all quiet and I thought: “Well, say something,
for God’s sake!” It’s at that point that she said: “Well,
no, that does not look good at all”. I just felt like
crying, because I could see for myself that it did look
really bad. Then they took the biopsies … And then
she said: “If it’s as bad as it seems, I’ll call you within
10 days.” After that, you just go around in a panic,
looking at your phone to see if someone has called,
and if it rings you think: “Is it her?” Because that
means it’s bad, right? (Woman who had not yet
received results from a colposcopy).
The participants said they would have liked more
compassion and better verbal and printed information about
cervical dysplasia at the time of diagnosis. Regardless of
the stage of dysplasia, they wanted to know about the
medical rationale for the intervals between check-ups, the
meaning of the test results, the possible consequences for
fertility and about HPVas the causal factor. Retrospectively,
the women who had undergone conisation felt that their
anxiety during the course of disease had been significantly
worsened by poor communication with the various doctors
and nurses. Some participants suggested that young
women in general should be better informed about cervical
dysplasia and that more women would participate in
screening programmes if they knew about the prevalence
of HPV and the association of HPV with cervical cancer.
They also felt that GPs should encourage Pap smear
testing when performing other gynaecological examina-
tions, for instance.
Discussion
The present study is, to our knowledge, the first of its kind
to assess and compare the experiences of young Danish
women diagnosed, via routine cytological screening, with
cervical dysplasia of varying grades of severity. The use of
qualitative research methods has produced an in-depth
account of how these young women react to and deal with
the diagnosis and management of this disease. The results
suggest that patients’ perceptions of cervical dysplasia
J Public Health (2010) 18:473–482 479significantly differ from those of medical professionals and
that women’s concerns are not aggravated in proportion to
the severity of the cervical dysplasia.
Our results show that the detection of cervical abnor-
malities, whatever their severity, leads to significant distress
and anxiety. As other studies have also shown, many
women are quite unprepared for the first abnormal result
because they had considered the test as a routine check-up
(French et al. 2006; Hounsgaard 2004).The participants in
our study were grouped according to whether they had or
had not undergone conisation. The results revealed,
contrary to what might be expected, that women diagnosed
with lower-grade lesions and who had not been conised
were more likely to experience anxiety and stress due to
their disease, since they lacked information about their
condition and the period of follow-up with regular check-
ups, before treatment is initiated or before regression of the
lesion is confirmed, can be long. From a medical viewpoint,
watchful waiting is a means of avoiding unnecessary
invasive treatment. From the women’s viewpoint, their
lives during this period of watchful waiting are full of
apprehension, waiting for check-ups and the subsequent
results and the fear that the lesion will probably ‘spread’ or
develop into cancer. The women diagnosed with lower-
grade lesions, in particular, had poor understanding of their
condition, its cause and the medical rationale for the follow-
up and treatment provided. Their anxiety was linked to
inadequate communication with medical professionals
(Bunge et al. 2009). This is in line with other studies
showing that women often have poor understanding of the
meaning of cervical smear test results (Lauver et al. 1999;
French et al. 2004, 2006; Lerman et al. 1991; Ideström et
al. 2003;N e a l ee ta l .2003; Campion et al. 1988;
McCaffery et al. 2004; Fleurence et al. 2007; Hounsgaard
2004; Maissi et al. 2004).
In this study, women with higher-grade lesions reported
less disease-related anxiety after conisation. To some, the
period of uncertainty had been shorter as prompt treatment
(conisation) was given, but most importantly, before
conisation they had received more information about the
causes and clinical management of cervical dysplasia,
which reassured them. Results from other studies have also
suggested that anxiety related to cervical dysplasia is closely
related to lack of knowledge (Lauver et al. 1999; French et
al. 2004, 2006; Lerman et al. 1991; Ideström et al. 2003;
Neale et al. 2003; Campion et al. 1988; McCaffery et al.
2004; Fleurence et al. 2007; Hounsgaard 2004).
Although we cannot exclude negative selection bias, i.e.
an over-representation of women with negative experiences
who are more likely to accept to participate, the results
from this study do not suggest that there was any. We know
that focus group methodology has the risk that unusual
experiences are under-reported and negative experiences
are over-reported (Halkier 2003). In this study, the focus
group participants did not restrain themselves from express-
ing singular perceptions. Moreover, participants were given
the opportunity to express themselves freely, without peer
group pressure, in the individual interviews (Bech Risør et
al. 2005; Kvale 1996; Spradley 1979).
This study was based on qualitative methodology and
thus included a relatively small number of participants.
Many of our results agree with those of previous studies
and we do not consider that more interviews would have
produced more qualitative knowledge from women targeted
by this study. However, it would be interesting to examine
the experiences of women who have been monitored for a
longer post-operative period. The women in this study who
had undergone conisation said they imagined that a
negative test result for the 6-month check-up after conisa-
tion would indicate cure and thus they could ‘start again’.
We did not include women who had had the results from
this check-up, so we cannot say if they would really have
felt that way. Results from other studies do not provide
clear-cut answers to whether the psychological effects of
having cervical dysplasia are short-term or of longer
duration (Lerman et al. 1991;I d e s t r ö me ta l .2003;
Hounsgaard 2004). Further studies should also investigate
the experiences of older women and those of women from
ethnic minorities and explore the effect of factors such as
knowledge of the sexual transmission of HPV on their
perception of disease.
Knowing that HPV is the cause of cervical dysplasia did
not seem to increase the worries of these young Danish
women or lead to feelings of stigma. Some previous studies
have suggested that knowing about the sexual transmission
of HPV can lead to feelings of empowerment and improve
health-related behaviour, for example, by encouraging
condom use and participation in screening programmes
for cervical cancer (Kahn et al. 2005). On the other hand,
others have suggested that this knowledge can lead to
women seeing cervical dysplasia as stigmatising (Waller et
al. 2005; McCaffery et al. 2006; Kahn et al. 2005, 2007;
Maissi et al. 2004; Waller et al. 2007; Clarke et al. 1996;
McCree and Dempsey 2005) and this may act as a barrier to
improved health-related behaviour (Waller et al. 2007). We
cannot exclude that some women may have not accepted to
participate in the present study because of this negative
perception. Perception of disease is highly dependent on
socio-cultural context (Kleinman 1988; Hahn 1984; Berger
and Luckmann 1987) and the young Danish women in our
study seemed to have associated cervical dysplasia with
cancer rather than with a sexually transmitted disease.
In Denmark, HPV vaccination has been included in the
childhood immunisation programme and, therefore, has
been free of charge since January 2009 for girls aged 12
and for 13- to 15-year-old girls in an initial catch-up
480 J Public Health (2010) 18:473–482programme. Provided that women’s participation in the
cervical screening programme remains unchanged, vacci-
nation is expected to prevent approximately 70% of
cervical cancer cases, i.e. those caused by HPV 16 or
HPV 18 (Bosch and Lorincz 2002; Trottier and Franco
2006; Smith et al. 2007). Our study suggests that the heavy
psychological burden experienced by women who are
diagnosed with cervical dysplasia during cervical screening
could also be greatly reduced by vaccination.
Our study has shown that it is important to address
women’s fear of cancer and need for information about
cervical dysplasia from the moment of diagnosis, regardless
of the stage of the lesion. Improved communication may
reduce the divergence between patients’ and practitioners’
perceptions of cervical dysplasia so that women may
understand the medical viewpoint of watchful waiting as a
reassuring means of monitoring the disease and avoiding
unnecessary treatment, rather than as a distressing delay.
Vaccinated women also need to understand that the vaccine
cannot prevent all cervical cancers and that it will still be
necessary to attend screening. With the proper communi-
cation about HPV being an extremely prevalent virus that
will infect almost everybody during their lifetime (National
Board of Health 2007b), there is a possibility of promoting
health care behaviour regarding the uptake of HPV
vaccination as well as participation in screening pro-
grammes for cervical cancer.
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